Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/56153 
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKobelt, Giselaen
dc.contributor.authorLindgren, Peteren
dc.contributor.authorSmala, Antjeen
dc.contributor.authorJönsson, Bengten
dc.date.accessioned2012-03-28T13:04:47Z-
dc.date.available2012-03-28T13:04:47Z-
dc.date.issued2000-
dc.identifier.urihttp://hdl.handle.net/10419/56153-
dc.description.abstractWe performed a cross-sectional, bottom-up observational study of resource consumption and quality of life of patients with multiple sclerosis (MS) in Germany. Six centers participated in the study. Patients were asked to complete a questionnaire, and a total of 737 patients returned the questionnaire (the answer rate being 66%). The questionnaire provided information on all resource consumption, medical and non-medical, work absence and informal care related to their MS. Simultaneously, medical charts were also abstracted for a sub sample of 202 patients. For this sub sample, disease scores (Expanded Disability Status Scale, EDSS) were available from the study centers. For the remainder, disease scores were assigned using a matrix of disease (mobility) descriptions and EDSS scores. Mean total cost per patient and year was 65,400 DM, adjusted for usage of interferons, which was higher in this sample than the current average usage in Germany. When this cost is extrapolated to an estimated patient population of 120,000, total costs to society are estimated at 7.85 billion DM. Direct costs represented 57.5%, informal care accounted for 12.1% and indirect costs amounted to 42.5%. An estimated 24,800 DM per patient or 38% of total costs are paid for by public payers. Intangible costs were estimated 16,650 DM per patient and year. The mean age of the cohort was 42 years (disease onset 33), the mean utility measured with EQ-5D was 0.552 (0.919 to -0.429), and the mean EDSS score 4.4 (1.0 to 9.5). All costs (direct, informal care, indirect) increased with increasing EDSS scores, while utilities decreased.en
dc.language.isoengen
dc.publisher|aStockholm School of Economics, The Economic Research Institute (EFI) |cStockholmen
dc.relation.ispartofseries|aSSE/EFI Working Paper Series in Economics and Finance |x399en
dc.subject.jelD61en
dc.subject.jelH42en
dc.subject.jelH51en
dc.subject.jelH55en
dc.subject.jelI18en
dc.subject.ddc330en
dc.subject.keywordmultiple sclerosisen
dc.subject.keywordcost-of-illnessen
dc.subject.keywordquality of lifeen
dc.subject.keywordEDSSen
dc.subject.keywordutilityen
dc.subject.stwKrankheiten
dc.subject.stwKostenen
dc.subject.stwLebensqualitäten
dc.subject.stwStatistischer Testen
dc.subject.stwDeutschlanden
dc.titleCosts and quality of life in multiple sclerosis: A cross-sectional observational study in Germany-
dc.typeWorking Paperen
dc.identifier.ppn333187628en
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungenen

Files in This Item:
File
Size
333.38 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.